Profit

Mixed results for pharma sector

PUBLISHED ON: January 18, 2008 | Duration: 3 min, 10 sec

  
loading..
Ranbaxy's profits beat expectations, Biocon's shot in the arm came from a plan to list its subsidiary Syngene. The revenues of Ranbaxy grew by 5.7 per cent to about Rs 1,800 crore for the fourth quarter ended December 31.
ALSO WATCH
Red Bull FMX Jam Mumbai - Freestyle Stunt Show

................................ Advertisement ................................

................................ Advertisement ................................